Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Acute Kidney Injury Research, and Trauma, Hemostasis, Coagulopathy, Resuscitation.
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: <scp>STEP</scp> 5
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials